Skip to main content

Table 3 ACR composite measure of mutant, non-mutant JAK2 RA patients

From: JAK2 mutation may predict response and guide first line treatment in rheumatoid arthritis

ACR

Non-mutant JAK2

Mutant JAK2

X

P

ACR 20 (38 patients)

12 (31.6%)

26 (68.4%)

7.8

0.022

ACR 50 (25 patients)

13 (52%)

12 (48%)

ACR 70 (22 patients)

15 (68.2%)

7 (31.8%)

  1. % in rows